Julie Gay
Bayonne, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Launching the Association of Hematology Department Heads: Sharing experiences and supporting one another for better leadership
Journal: Bulletin du cancer
Published: March 13, 2026
Measurable Residual Disease-Guided Therapy in Newly Diagnosed Myeloma.
Journal: The New England journal of medicine
Published: June 03, 2025
Real-World Evidence Supports Venetoclax as an Additional Option for Patients With t(11;14) Myeloma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 26, 2025
Iberdomide, ixazomib and dexamethasone in elderly patients with multiple myeloma at first relapse.
Journal: British journal of haematology
Published: November 05, 2024
Real-Life Management of Patients Aged 80 Years Old and Over With Multiple Myeloma: Results of the EMMY Cohort.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 13, 2024
Nurturing and growing a community of department heads: Act 2 in haematology
Journal: Bulletin du cancer
Published: May 03, 2024
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial.
Journal: Nature medicine
Published: April 18, 2024
Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial.
Journal: Nature communications
Published: February 19, 2024
Twice-weekly induction with ixazomib-lenalidomide-dexamethasone (IRd) combination followed by extended IRd consolidation and lenalidomide maintenance in transplant-eligible patients with newly diagnosed multiple myeloma: Results of the phase 2 study IFM2014-03.
Journal: British journal of haematology
Published: January 05, 2024
NPM1 mutation is not associated with prolonged complete remission in acute myeloid leukemia patients treated with hypomethylating agents.
Journal: Haematologica
Published: May 12, 2018
Last Updated: 09/26/2026